Skip to main content

19 October 2025

Last updated: Sunday 19 October 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Trends in investment for cell and gene therapies

Sunday 23 February 2025

Interviewee/Contributor

Paola Pozzi

Organisation

Sofinnova Partners Telethon Strategy

Sofinnova's Investment Strategy: Putting the entrepreneur first

Friday 18 January 2013

Interviewee/Contributor

Antoine Papiernik

Organisation

Sofinnova Partners

Organisations

Adrenomed AG
Marks and Clerk LLP
Arecor Ltd
Ariceum Therapeutics GmbH
Edmond de Rothschild Partners
F2G Ltd
Humabs BioMed SA
IP Group
Forbion Capital Partners
Anergis SA

Interviewees and Contributers

Jean-Philippe Tripet
Nigel Davis
Don Picker
John Fielden
Dr Jochen Klupp
Peter Heinrich
Ravi Nalliah
Christian Wandersee
Reisa Sperling
Olivier Litzka

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

CHARM Therapeutics appoints CMO

Tuesday 16 September 2025

Abzena appoints CEO

Tuesday 16 September 2025

OMass Therapeutics appoints director

Tuesday 16 September 2025

Maxion Therapeutics appoints non-executive director

Tuesday 16 September 2025

AlzeCure Pharma appoints head of development

Tuesday 16 September 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form